Recent YSCC Discoveries

Seventeen Yale Ob/Gyn faculty members have been recognized in Connecticut Magazine's 2026 “Top Doctors” edition.

Yale Cancer Center faculty and trainees joined over 22,000 cancer researchers from around the world to share the latest advances in cancer science and medicine earlier this week in San Diego for the 117th American Association for Cancer Research (AACR) annual meeting.

David Stitelman, MD, has received funding from the Cystic Fibrosis Research Institute to advance his collaborative research on a novel fetal therapy approach for cystic fibrosis. Working with colleagues across pediatric pulmonology, biomedical engineering, and gene editing, his team is developing nanoparticle-based strategies to deliver gene therapies before birth—aimed at preventing organ damage that begins in utero. By combining mRNA delivery and high-fidelity gene editing, this work has the potential to move toward a one-time treatment for cystic fibrosis and establish a new paradigm for treating genetic diseases before birth.

The iPSC Neurocore of the Department of Neuroscience, led by Tanina Arab, PhD, and the STEM Cell core of the STEM Cell Center, led by Caihong Qiu, PhD, are among the recipients.

Why do some lung cancers stop responding to drugs that once worked? And why does the immune system sometimes fail to recognize and destroy tumors? Pathologist Katerina Politi, PhD, has spent more than two decades pursuing those questions, and her team at Yale School of Medicine is now closer to finding answers that could reshape how patients are treated.

Yong-Hui Jiang’s research has uncovered the biology of neurogenetic disorders like Angelman syndrome and autism. His genome-editing work could lead to targeted therapies.

On Tuesday, April 7, 2026, the Center for Thoracic Cancers hosted a special event for patients and caregivers, with Annabelle Gurwitch.

The annual Yale-NAMI Conference on Neuroscience, Mental Health and Society, sponsored by the Yale Department of Psychiatry, will be held Saturday, May 9, beginning at 8 am at The Anlyan Center Auditorium, 300 Cedar St., New Haven.

Yale Cancer Center Experts to Present Latest Findings